Your browser doesn't support javascript.
loading
The transcription factor ETS1 in lymphomas: friend or foe?
Testoni, Monica; Chung, Elaine Yee Lin; Priebe, Valdemar; Bertoni, Francesco.
Afiliação
  • Testoni M; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research , Bellinzona , Switzerland.
Leuk Lymphoma ; 56(7): 1975-80, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25363344
ABSTRACT
ETS1 is a member of the ETS family of transcription factors, which contains many cancer genes. ETS1 gene is mapped at 11q24.3, a chromosomal region that is often the site of genomic rearrangements in hematological cancers. ETS1 is expressed in a variety of cells, including B and T lymphocytes. ETS1 is important in various biological processes such as development, differentiation, proliferation, apoptosis, migration and tissue remodeling. It acts as an oncogene controlling invasive and angiogenic behavior of malignant cells in multiple human cancers. In particular, ETS1 deregulation has been reported in diffuse large B-cell lymphoma, in Burkitt lymphoma and in Hodgkin lymphoma. Here, we summarize the function of ETS1 in normal cells, with a particular emphasis on lymphocytes, and its possible role as an oncogene or tumor suppressor gene in the different mature B cell lymphomas.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Genes Supressores de Tumor / Proteína Proto-Oncogênica c-ets-1 / Linfoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Genes Supressores de Tumor / Proteína Proto-Oncogênica c-ets-1 / Linfoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça